Key Metrics
9.3
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
1.19
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
Topics Covered
- Oligonucleotide
- RNA interference
- RNA editing
- Guide RNA
- Exon
- Amyloid precursor protein
- Antisense oligonucleotides
- Minicircle dna
- Serum protein
- Duchenne muscular dystrophy
- Exon skipping
- DNA Aptamers
- Antisense RNA
- Amyloid angiopathy
- Type 2 diabetes
- Protein splicing
- G-quadruplex
- RNA Aptamers
- Ribosomal protein
Journal Specifications
| Overview | |
| Publisher | MARY ANN LIEBERT, INC |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2011 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in Nucleic Acid Therapeutics ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
A Combined Fertility and Developmental Toxicity Study with an Antisense Oligonucleotide Targeting Murine Apolipoprotein C-III mRNA in Mice.
- 25 Nov 24
- Nucleic acid therapeutics
-
Full paper
It is Time to Revisit miRNA Therapeutics.
- 21 Nov 24
- Nucleic acid therapeutics
-
Full paper
Antisense Oligonucleotide STK-002 Increases OPA1 in Retina and Improves Mitochondrial Function in Autosomal Dominant Optic Atrophy Cells.
- 1 Oct 24
- Nucleic acid therapeutics
-
Full paper
Rosalind Franklin Society Proudly Announces the 2023 Award Recipient for Nucleic Acid Therapeutics.
- 1 Oct 24
- Nucleic acid therapeutics
-
Full paper
Addressing the Challenges of Treating Patients with Heterozygous Gain of Function Mutations.
- 23 Sep 24
- Nucleic acid therapeutics
-
Full paper
An Evaluation of First-in-Human Studies for RNA Oligonucleotides.
- 23 Sep 24
- Nucleic acid therapeutics
FAQs
How long has Nucleic Acid Therapeutics been actively publishing?
Nucleic Acid Therapeutics has been in operation since 2011 till date.
What is the publishing frequency of Nucleic Acid Therapeutics ?
Nucleic Acid Therapeutics published with a Bi-monthly frequency.
How many articles did Nucleic Acid Therapeutics publish last years ?
In 2023, Nucleic Acid Therapeutics published 26 articles.
What is the eISSN & pISSN for Nucleic Acid Therapeutics ?
For Nucleic Acid Therapeutics,eISSN is 2159-3345 and pISSN is2159-3337.
What is Citescore for Nucleic Acid Therapeutics ?
Citescore for Nucleic Acid Therapeutics is 9.3.
What is SNIP score for Nucleic Acid Therapeutics ?
SNIP score for Nucleic Acid Therapeutics is 1.19.
Who is the publisher of Nucleic Acid Therapeutics ?
MARY ANN LIEBERT, INC is the publisher of Nucleic Acid Therapeutics.